$20MVenture, 30 April 2026
Funds its functional profiling platform and US expansion; Ole Dahlberg joins the board.
- Amount
- $20M
- Stage
- Venture
- Announced
- 30 April 2026
- Lead
- Rubicon Healthcare Partners
- Other investors
- ARCH Venture Partners, Eir Ventures
- Use of funds
- Funds its functional profiling platform and US expansion; Ole Dahlberg joins the board.
- Checked
- Announced by the company
- Sources
- Moleculent raises $20M (date approx) biospace.com
Moleculent raises $20M (date approx) pulse2.com